ATE183081T1 - Doxorubicine enkapsulierende liposomen - Google Patents

Doxorubicine enkapsulierende liposomen

Info

Publication number
ATE183081T1
ATE183081T1 AT94500197T AT94500197T ATE183081T1 AT E183081 T1 ATE183081 T1 AT E183081T1 AT 94500197 T AT94500197 T AT 94500197T AT 94500197 T AT94500197 T AT 94500197T AT E183081 T1 ATE183081 T1 AT E183081T1
Authority
AT
Austria
Prior art keywords
doxorubicine
encapsulating liposomes
liposomes
encapsulating
cf3ch2o
Prior art date
Application number
AT94500197T
Other languages
English (en)
Inventor
Lambiez Fernando Pons
Gonzalez Raquel Delgado
Duena Antonio Parente
Original Assignee
Lipotec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec Sa filed Critical Lipotec Sa
Application granted granted Critical
Publication of ATE183081T1 publication Critical patent/ATE183081T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT94500197T 1993-11-25 1994-11-25 Doxorubicine enkapsulierende liposomen ATE183081T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09302481A ES2072223B1 (es) 1993-11-25 1993-11-25 Liposomas encapsulando doxorubicina.

Publications (1)

Publication Number Publication Date
ATE183081T1 true ATE183081T1 (de) 1999-08-15

Family

ID=8283745

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94500197T ATE183081T1 (de) 1993-11-25 1994-11-25 Doxorubicine enkapsulierende liposomen

Country Status (8)

Country Link
US (1) US5605703A (de)
EP (1) EP0655239B1 (de)
JP (1) JP4256930B2 (de)
AT (1) ATE183081T1 (de)
DE (1) DE69420012T2 (de)
DK (1) DK0655239T3 (de)
ES (1) ES2072223B1 (de)
WO (1) WO1995014459A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2154560B1 (es) * 1998-09-16 2001-12-01 Lipotec Sa Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.
IT1315253B1 (it) * 1999-10-22 2003-02-03 Novuspharma Spa Preparazione liposomiale di 6,9-bis-(2-amminoetil)ammino|benzog|isochinolin-5,10-dione dimaleato
FR2808189B1 (fr) 2000-04-28 2004-03-05 Oreal Lipochroman-6 comme inhibiteur de no-synthase et utilisations
ES2186484B1 (es) 2000-10-10 2004-07-01 Lipotec, S.A. Liposomas encapsulando farmacos anticancerosos y uso de los mismos en el tratamiento de tumores malignos.
US7029695B2 (en) * 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
EP1463487B1 (de) * 2001-12-19 2010-05-19 Research Development Foundation Liposomale abgabe von verbindungen auf vitamin-e-basis
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
US20050058698A1 (en) * 2002-01-21 2005-03-17 Nolan Yvonne Mairead Pharmaceutically acceptable phosphate-glycerol carrying bodies and uses relating to Parkinson's Disease
CA2368656A1 (en) * 2002-01-21 2003-07-21 Vasogen Ireland Limited Receptor-ligand pairing for anti-inflammatory response
DE10259014A1 (de) 2002-12-16 2004-06-24 Henkel Kgaa Antioxidans-Kombinationen mit6,7-disubstituierten 2,2-Dialkylchromanen oder-chromenen
US20050009772A1 (en) * 2003-05-06 2005-01-13 The Regents Of The University Of California Methods and compositions for the treatment of glaucoma and other retinal diseases
CA2574802A1 (en) 2004-07-20 2006-02-02 Isogenis, Inc. Specific inhibition of autoimmunity and diseases associated with autoantigens
US7470672B2 (en) * 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
US7750018B2 (en) * 2006-12-06 2010-07-06 Tactical Therapeutics, Inc Use of carboxiamidotriazole (CAI) orotate in macular degeneration
DE102006062501A1 (de) 2006-12-28 2008-07-03 Henkel Kgaa Kosmetische und dermatologische Öl-in-Wasser-Emulsionen mit selbstkonservierenden Eigenschaften
ES2310142B1 (es) * 2007-06-15 2009-12-04 Lipotec S.A Compuestos reguladores de la pigmentacion.
WO2010127271A1 (en) 2009-04-30 2010-11-04 Intezyne Technologies, Incorporated Polymer micelles containing anthracylines for the treatment of cancer
US8524784B2 (en) 2009-04-30 2013-09-03 Intezyne Technologies, Incorporated Polymer micelles containing anthracylines for the treatment of cancer
DE102009026414A1 (de) 2009-05-22 2010-11-25 Henkel Ag & Co. Kgaa Hautbehandlung zur Porenverfeinerung
US20130195962A1 (en) * 2010-04-28 2013-08-01 National University Corporation Hokkaido University Lipid membrane structure
CN103083239B (zh) 2012-12-26 2015-11-25 中国人民解放军第四军医大学 一种蟾毒灵脂质体及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153955A1 (de) * 1983-09-06 1985-09-11 Health Research, Inc. Verfahren zum verabreichen von liposomen zum herabsetzen der toxizität eines antitumor-arzneimittels
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
AU7128887A (en) * 1986-02-10 1987-08-25 Liposome Technology, Inc. Controlled-release liposome delivery system
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
DE4000397A1 (de) * 1990-01-09 1991-07-11 Hoechst Ag Lipidselektive antioxidantien sowie deren herstellung und verwendung
WO1992002208A1 (en) * 1990-08-08 1992-02-20 Liposome Technology, Inc. Stable doxorubicin/liposome composition
CA2055990A1 (en) * 1990-11-22 1992-05-23 David G. Schena Phospholipid-vitamin derivatives and methods for preparation thereof

Also Published As

Publication number Publication date
EP0655239A1 (de) 1995-05-31
EP0655239B1 (de) 1999-08-11
WO1995014459A1 (es) 1995-06-01
DE69420012D1 (de) 1999-09-16
US5605703A (en) 1997-02-25
JP4256930B2 (ja) 2009-04-22
JPH08506124A (ja) 1996-07-02
DK0655239T3 (da) 2000-03-20
DE69420012T2 (de) 2000-03-23
ES2072223A1 (es) 1995-07-01
ES2072223B1 (es) 1996-03-16

Similar Documents

Publication Publication Date Title
DE69420012D1 (de) Doxorubicine enkapsulierende Liposomen
ES2070628T3 (es) Uso de compuestos analogos a 1,3-oxatiolano-nucleosidos en la fabricacion de un medicamento para el tratamiento de la hepatitis b.
MY105328A (en) Blocking agents of edrf effect or formation for the treatment of shock.
ATE174899T1 (de) Zytotoxische stilben-derivate und diese enthaltende pharmazeutische zusammensetzungen
GEP20002210B (en) Acridine Derivatives
GR3022631T3 (en) Trifluoromethylketone derivatives of peptides having HLE inhibiting activity, their preparation and pharmaceutical composition
AU689304B2 (en) Quinazoline derivative
DE69200290D1 (de) Thienopyridin -Derivative und diese enthaltende Arzneimittel.
IL101839A0 (en) Peptide compounds,processes for the preparation thereof,and pharmaceutical compositions containing the same
DE69001111D1 (de) Antikrebs-zusammensetzung.
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
EP0546177A4 (de) Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält.
EP0551527B8 (de) Pyrroloazepinderivate
FI911138A0 (fi) Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
MX9206930A (es) Nuevos compuestos
FI903692A0 (fi) Salter av n5, n10-metylen-5,6,7,8- tetrahydrofolsyra.
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
EP0630899A4 (de) Cephem-verbindungen, verfarhren zu ihrer herstellung und diese enthaltende medikamente.
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
AU639875B2 (en) 5-amino-5,6,7,8-tetrahydroquinolines and related compounds and pharmaceutical use
ATE58129T1 (de) Dem antibiotikum tan-749 aehnliche verbindungen und ihre herstellung.
AU581440B2 (en) Benzoseleno ``4,3,2-cd`` indazole compositions and methods for their production and use
ATE255121T1 (de) Antitumor-indolopyrolocarbazolderivat
AU1287892A (en) Method of inhibiting the progressive development of diabetes mellitus
IL106564A (en) Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them